title: [Treatment of adult T-cell leukemia-lymphoma].
authors.forename: Takuya
authors.initials: T
authors.lastname: Fukushima
mesh_terms: D064591:Allografts; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D015368:Human T-lymphotropic virus 1; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000453:epidemiology / Q000628:therapy* / Q000821:virology; D008727:Methotrexate / Q000008:administration & dosage; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D016879:Salvage Therapy; D014750:Vincristine / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage; D015215:Zidovudine / Q000008:administration & dosage
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D016898:Interferon-alpha; D009607:Nitrosourea Compounds; D001761:Bleomycin; D015251:Epirubicin; D015215:Zidovudine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D016190:Carboplatin; D014751:Vindesine; D011241:Prednisone; C549035:mogamulizumab; D008727:Methotrexate